Niche folate therapies Privately held JayMac focuses on FDA-regulated folate therapies for psychiatric and high-risk pregnancy markets, presenting a clear upsell opportunity to expand within folate-related indications and centers of excellence.

Hybrid sales model With a robust inside sales force and hybrid territory approach, there is potential to scale outreach to psychiatry clinics, OB/GYN practices, and specialty pharmacies through targeted campaigns and repeatable playbooks.

Private-label partnerability Proprietary products EnLyte and EnBrace HR may attract collaborations or private-label opportunities with larger pharma distributors or specialty care networks seeking differentiated folate therapies.

Emerging market potential Strong demand for folate-related treatments in psychiatric and obstetric care suggests growth opportunities in regional hospitals, long-term care facilities, and integration into perinatal mental health programs.

Sustainability and security Adherence to modern web and security standards (HSTS, HTTP/3, X-Content-Type-Options) signals reliability; leverage this as a selling point when engaging payers, distributors, and healthcare IT teams seeking secure product integrations.